Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Philips raises awareness for chronic obstructive pulmonary disease (COPD) with platinum sponsorship of Leonard Nimoy tribute documentary

Amsterdam, Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced its sponsorship of the documentary COPD: Highly Illogical - Remembering Leonard Nimoy. The documentary seeks to educate viewers about COPD through Leonard Nimoy’s personal story of courage, while also providing the latest information about treatments for the chronic disease.

Ethicon Establishes Unmatched Knotless Suture Portfolio With Launch of Stratafix Spiral Plus Devices

PR Newswire, CINCINNATI, Aug. 22, 2016: Ethicon*, a trusted leader in advancing wound closure, announces the launch of STRATAFIX™ Spiral PDS Plus and STRATAFIX™ Spiral Monocryl Plus Knotless Tissue Control Devices. 

Using Tc 99m PYP cardiac imaging may help diagnose and detect patients with heart failure

A retrospective cohort study found that using technetium 99m pyrophosphate (Tc 99m PYP) cardiac imaging helped detect and diagnose patients with transthyretin-related cardiac amyloidosis, a cause of heart failure with preserved ejection fraction.

Medtronic Completes Acquisition of HeartWare International

DUBLIN - Aug. 23, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, has completed its acquisition of HeartWare International, Inc., a leading innovator of less-invasive, miniaturized, mechanical circulatory support technologies (MCS) for treating patients with advanced heart failure.

Endologix Announces First Patients Treated with Ovation Alto™ Abdominal Stent Graft System

Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the first two patients with abdominal aortic aneurysms (“AAA”) have been treated with the Ovation Alto™ Abdominal Stent Graft System. The patients were treated by Andrew Holden, MD, and Andrew Hill, MD, of Auckland City Hospital, Auckland, New Zealand.

Researchers develop ECG risk equation to predict cardiovascular disease mortality

Researchers have developed a risk score based on demographics and automated electrocardiography (ECG) data that performs comparably to the Framingham risk score and the pooled cohort equation when assessing possible cardiovascular disease mortality.

Edwards Receives Approval For SAPIEN 3 Heart Valve In Canada

IRVINE, Calif., July 27, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that Health Canada has approved the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients living with severe, symptomatic aortic stenosis and at high or greater risk for surgical aortic valve replacement.

Thumbnail

Screening college athletes with ECGs remains a hot topic

Based on their discussions and research, the committee could not recommend that all athletes undergo screening with an ECG.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.